Paperback
|
Engels
€ 65,95
- Vanaf €15,- geen verzendkosten.
- 30 dagen ruiltermijn voor fysieke producten
Omschrijving
“This new book analyzes corporate governance in Japan from the perspective of a practitioner at the forefront of the business world and will help global investors understand Japan Inc. as it is today.” (Translated from Japanese, Ryohei Yanagi, Nikkei Sangyo Shimbun, July 19, 2018)
“This new book analyzes corporate governance in Japan from the perspective of a practitioner at the forefront of the business world and will help global investors understand Japan Inc. as it is today.” (Translated from Japanese, Ryohei Yanagi, Nikkei Sangyo Shimbun, July 19, 2018)
Ryohei Yanagi is Chief Financial Officer of Eisai Co., Ltd., one of the largest pharmaceutical companies in Japan. He is also Visiting Professor at Toyo University and Visiting Lecturer at Waseda University Graduate School of Accountancy, where he teaches corporate governance, corporate finance and investor relations. He earned his Ph.D. from Kyoto University. During the last 15 years, Dr. Yanagi has conducted approximately 3,000 meetings in the aggregate with global investors (about 200 meetings per annum) throughout his career with UBS as Executive Director and at Eisai as CFO. He was selected as the Best CFO in Japan’s healthcare sector in 2016 and 2017 by the Institutional Investor magazine. He was also ranked in the Top 10 CFOs by Forbes Japan for the second consecutive year. In addition, Dr. Yanagi has served as advisor to the Tokyo Stock Exchange and the Ministry of Economy, Trade and Industry (METI), including the Ito Review. He is Secretary of the Institute of Management Accountants (IMA) Tokyo Chapter as a certified management accountant, and has written and published many books and theses on his research agenda.
“This new book analyzes corporate governance in Japan from the perspective of a practitioner at the forefront of the business world and will help global investors understand Japan Inc. as it is today.” (Translated from Japanese, Ryohei Yanagi, Nikkei Sangyo Shimbun, July 19, 2018)
Ryohei Yanagi is Chief Financial Officer of Eisai Co., Ltd., one of the largest pharmaceutical companies in Japan. He is also Visiting Professor at Toyo University and Visiting Lecturer at Waseda University Graduate School of Accountancy, where he teaches corporate governance, corporate finance and investor relations. He earned his Ph.D. from Kyoto University. During the last 15 years, Dr. Yanagi has conducted approximately 3,000 meetings in the aggregate with global investors (about 200 meetings per annum) throughout his career with UBS as Executive Director and at Eisai as CFO. He was selected as the Best CFO in Japan’s healthcare sector in 2016 and 2017 by the Institutional Investor magazine. He was also ranked in the Top 10 CFOs by Forbes Japan for the second consecutive year. In addition, Dr. Yanagi has served as advisor to the Tokyo Stock Exchange and the Ministry of Economy, Trade and Industry (METI), including the Ito Review. He is Secretary of the Institute of Management Accountants (IMA) Tokyo Chapter as a certified management accountant, and has written and published many books and theses on his research agenda.